Methodology previously described by our group was applied to the preparation of a series of 4-alkyl/aryl-substituted 1-[benzofuran-2-yl-phenylmethyl]-1H-triazoles. The [1, 2, 4]-triazole derivatives were prepared for a range of alkyl and aryl substituents, and for the 4-methyl, 4- ethyl, 4-ipropyl, 4-tbutyl, 4-phenyl and 4-chlorophenyl derivatives, the minor [1, 3, 4]-triazole isomer also isolated. All the triazole derivatives were evaluated for CYP26A1 inhibitory ...